Tag - Regeneron

23andMe Reaches Agreement for Sale of Business to TTAM Research Institute Following Final Round of Bidding in Court-Approved Sale Process

Dozens of states sue to block the sale of 23andMe personal genetic data without customer consent

Regeneron Enters into Asset Purchase Agreement to Acquire 23andMe® for $256 Million; Plans to Maintain Consumer Genetics Business and Advance Shared Goals of Improving Human Health and Wellness

AGBT 2025 – And the Winner is, Drum Roll, Sequencing

Goodbye 2022 – Hello 2023

Enlightenbio Releases New Report – Database of Biomarkers Curated from US Oncology Trials

2020 Was Not Just About COVID-19

UK Biobank launches one of the largest scientific studies measuring circulating proteins, to better understand the link between genetics and human disease

DNAnexus Completes $100 Million Financing

Regeneron And Colorado Center For Personalized Medicine Announce Major New Human Genetics Research Collaboration

2019 in Review – Major Acquisitions, Population Studies, Gigantic Founding Rounds, Technological Advancements, and ….

BioIT 2019: The New “Official” Future Involves Data Sharing, Artificial Intelligence, Open Source, and More

JP Morgan 2019 – Drug pricing, drug development, immunotherapy, cancer moonshot, cell/gene-therapy, …

AHSG 2017 Roundup – A Shout Out to the Women in Science

At ASHG 2014 genomics was everywhere, with big data and variant analysis/interpretation

Copyright © 2026. enlighenbio LLC. All rights reserved.